<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US6096329 - Synergistic mixture containing fipronil - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Synergistic mixture containing fipronil"><meta name="DC.contributor" content="Philippe Jeannin" scheme="inventor"><meta name="DC.contributor" content="Merial" scheme="assignee"><meta name="DC.date" content="1997-5-27" scheme="dateSubmitted"><meta name="DC.description" content="Process and composition, in particular for controlling fleas on small mammals, characterized in that the composition includes, on the one hand, at least one insecticide of 1-N-arylpyrazole type, in particular fipronil, and, on the other hand, at least one compound of IGR (insect growth regulator) type, in doses and proportions which are parasiticidally effective on fleas, in a fluid vehicle which is acceptable for the animal and convenient for local application to the skin, preferably localized over a small surface area."><meta name="DC.date" content="2000-8-1" scheme="issued"><meta name="DC.relation" content="US:5516787" scheme="references"><meta name="DC.relation" content="US:5567429" scheme="references"><meta name="DC.relation" content="US:5629334" scheme="references"><meta name="DC.relation" content="WO:1998025466:A1" scheme="references"><meta name="citation_patent_number" content="US:6096329"><meta name="citation_patent_application_number" content="US:08/863,692"><link rel="canonical" href="http://www.google.com/patents/US6096329"/><meta property="og:url" content="http://www.google.com/patents/US6096329"/><meta name="title" content="Patent US6096329 - Synergistic mixture containing fipronil"/><meta name="description" content="Process and composition, in particular for controlling fleas on small mammals, characterized in that the composition includes, on the one hand, at least one insecticide of 1-N-arylpyrazole type, in particular fipronil, and, on the other hand, at least one compound of IGR (insect growth regulator) type, in doses and proportions which are parasiticidally effective on fleas, in a fluid vehicle which is acceptable for the animal and convenient for local application to the skin, preferably localized over a small surface area."/><meta property="og:title" content="Patent US6096329 - Synergistic mixture containing fipronil"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("8IntU621F8W4sASeoYLICw"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("FRA"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("8IntU621F8W4sASeoYLICw"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("FRA"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us6096329?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US6096329"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=pmJQBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS6096329&amp;usg=AFQjCNEHt64B2csAqw1sdh7M9jHET1MSeQ" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US6096329.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US6096329.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US6096329" style="display:none"><span itemprop="description">Process and composition, in particular for controlling fleas on small mammals, characterized in that the composition includes, on the one hand, at least one insecticide of 1-N-arylpyrazole type, in particular fipronil, and, on the other hand, at least one compound of IGR (insect growth regulator) type,...</span><span itemprop="url">http://www.google.com/patents/US6096329?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US6096329 - Synergistic mixture containing fipronil</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US6096329 - Synergistic mixture containing fipronil" title="Patent US6096329 - Synergistic mixture containing fipronil"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US6096329 A</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 08/863,692</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Aug 1, 2000</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">May 27, 1997</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Mar 29, 1996</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2221418A1">CA2221418A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2221418C">CA2221418C</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2553413A1">CA2553413A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2553413C">CA2553413C</a>, </span><span class="patent-bibdata-value"><a href="/patents/CN1185716A">CN1185716A</a>, </span><span class="patent-bibdata-value"><a href="/patents/CN101732309A">CN101732309A</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE19780440B3">DE19780440B3</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE19780440T0">DE19780440T0</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE19780440T1">DE19780440T1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE19782314A5">DE19782314A5</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE19782315A5">DE19782315A5</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE19782316A5">DE19782316A5</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE19782317A5">DE19782317A5</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6685954">US6685954</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20020090387">US20020090387</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO1997036485A1">WO1997036485A1</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">08863692, </span><span class="patent-bibdata-value">863692, </span><span class="patent-bibdata-value">US 6096329 A, </span><span class="patent-bibdata-value">US 6096329A, </span><span class="patent-bibdata-value">US-A-6096329, </span><span class="patent-bibdata-value">US6096329 A, </span><span class="patent-bibdata-value">US6096329A</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Philippe+Jeannin%22">Philippe Jeannin</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Merial%22">Merial</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US6096329.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6096329.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6096329.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (4),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (51),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (31),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (10)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/6096329&usg=AFQjCNEv6QWNhzVgX1MHRoX8ohePTx4ujg">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D6096329&usg=AFQjCNEVLtDx7H0zpWOY9QfugAqa_bCWbA">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D6096329A%26KC%3DA%26FT%3DD&usg=AFQjCNGDRFIfASNhHNth247XR_PNpAf1qQ">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT129053375" lang="EN" load-source="ifi">Synergistic mixture containing fipronil</invention-title></span><br><span class="patent-number">US 6096329 A</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA38104617" lang="EN" load-source="patent-office"> <div class="abstract">Process and composition, in particular for controlling fleas on small mammals, characterized in that the composition includes, on the one hand, at least one insecticide of 1-N-arylpyrazole type, in particular fipronil, and, on the other hand, at least one compound of IGR (insect growth regulator) type, in doses and proportions which are parasiticidally effective on fleas, in a fluid vehicle which is acceptable for the animal and convenient for local application to the skin, preferably localized over a small surface area.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(16)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-0.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-0.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-6.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-6.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-7.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-7.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-8.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-8.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-9.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-9.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-10.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-10.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-11.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-11.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-12.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-12.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-13.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-13.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-14.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-14.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6096329-15.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6096329-15.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(70)</span></span></div><div class="patent-text"><div mxw-id="PCLM59573946" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>What is claimed is:</claim-statement> <div class="claim"> <div num="1" class="claim">
      <div class="claim-text">1. A synergistic spot-on composition for the long lasting protection against fleas and ticks on mammals which comprises synergistic effective amounts of Fipronil synergistic amount of a compound which mimics juvenile hormones and at least one customary spot-on formulation adjuvant.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" class="claim">
      <div class="claim-text">2. The synergistic composition according to claim 1 wherein the compound which mimics juvenile hormones is selected from the group consisting of azadirachtin, diofenolan, fenoxycarb, hydroprene, kinoprene, methoprene, pyriproxyfen, tetrahydroazadirachtin and 4-chloro-2-(2-chloro-2-methyl-propyl)-5-(6-iodo-3-pyridylmethoxy) pyridizine-3(2II)-one.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" class="claim">
      <div class="claim-text">3. The synergistic composition according to claim 1, wherein the compound which mimics juvenile hormones is methopren or pyriproxyfen.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" class="claim">
      <div class="claim-text">4. The synergistic composition according to claim 1, wherein the compound which mimics juvenile hormones is methopren.</div>
    </div>
    </div> <div class="claim"> <div num="5" class="claim">
      <div class="claim-text">5. A synergistic spot-on composition for long-lasting protection against fleas on mammals comprising synergistic amounts of at least one compound (A) of the formula ##STR2## in which: R<sub>1</sub> is CN or methyl or a halogen atom;<div class="claim-text">R<sub>2</sub> is S(O)<sub>n</sub> R<sub>3</sub> or 4,5-dicyanoimidazol-2-yl or haloalkyl;</div> <div class="claim-text">R<sub>3</sub> is alkyl or haloalkyl;</div> <div class="claim-text">R<sub>4</sub> represents a hydrogen or halogen atom; or a radical NR<sub>5</sub> R<sub>6</sub>, S(O)<sub>m</sub> R<sub>7</sub>, C(O)R<sub>7</sub>, C(O)O--R-<sub>7</sub>, alkyl, haloalkyl or OR<sub>8</sub> or a radical --N═C(R<sub>9</sub>) (R<sub>10</sub>);</div> <div class="claim-text">R<sub>5</sub> and R<sub>6</sub> independently represent a hydrogen atom or an alkyl, haloalkyl, C(O)alkyl, alkoxycarbonyl or S(O)<sub>r</sub> --CF<sub>3</sub> radical; R<sub>6</sub> and R<sub>6</sub> may together form a divalent alkylene radical which may be interrupted by one or two divalent hetero atoms;</div> <div class="claim-text">R<sub>7</sub> represents an alkyl or haloalkyl radical;</div> <div class="claim-text">R<sub>8</sub> represents an alkyl or haloalkyl radical or a hydrogen atom;</div> <div class="claim-text">R<sub>10</sub> represents a phenyl or heteroaryl group optionally substituted with one or more halogen atoms or groups such as OII, --O-alkyl, S-alkyl, cyano or alkyl;</div> <div class="claim-text">R<sub>11</sub> and R<sub>12</sub> represent, independently of each other, a hydrogen or halogen atom, or optionally CN or NO<sub>2</sub> ;</div> <div class="claim-text">R<sub>13</sub> represents a halogen atom or a haloalkyl, haloalkoxy, S(O)<sub>q</sub> CF<sub>3</sub> or SF<sub>5</sub> group;</div> <div class="claim-text">m, n, q and r represent, independently of each other, an integer equal to 0, 1 or 2;</div> <div class="claim-text">X represents a trivalent nitrogen atom or a radical C--R<sub>12</sub>, the other three valency positions of the carbon atom forming part of the aromatic ring;</div> <div class="claim-text">with the proviso that when R<sub>1</sub> is methyl, then R<sub>3</sub> is haloalkyl, R<sub>4</sub> is NH<sub>2</sub>, R<sub>11</sub> is Cl, R<sub>13</sub> is CF<sub>3</sub> and X is N; or R<sub>2</sub> is 4,5-dicyanoimidazol-2-yl, R<sub>4</sub> is Cl, R<sub>11</sub> is Cl, R<sub>13</sub> is CF<sub>3</sub> and X is ═C--Cl;</div> <div class="claim-text">a synergistic amount of at least one ovicidal compound (B), of insect growth regulator (IGR) type, in a fluid vehicle which is acceptable to the animal and suitable for local application to the skin; and at least one customary spot-on formulation adjuvant.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="6" class="claim">
      <div class="claim-text">6. Composition according to claim 5, characterized in that the compound of formula (I) is such that:<div class="claim-text">R<sub>1</sub> is CN or methyl</div> <div class="claim-text">R<sub>2</sub> is S(O)<sub>n</sub> R<sub>3</sub> </div> <div class="claim-text">R<sub>3</sub> is alkyl or haloalkyl</div> <div class="claim-text">R<sub>4</sub> represents a hydrogen or halogen atom; or a radical NR<sub>5</sub> R<sub>6</sub>, S(O)<sub>m</sub> R<sub>7</sub>, C(O)R<sub>7</sub>, alkyl, haloalkyl or OR<sub>8</sub> or a radical ---N═C(R<sub>9</sub>) (R<sub>10</sub>)</div> <div class="claim-text">R<sub>5</sub> and R<sub>6</sub> independently represent a hydrogen atom or an alkyl, haloalkyl, C(O)alkyl or S(O)<sub>r</sub> --CF<sub>3</sub> radical; or R<sub>5</sub> and R<sub>6</sub> may together form a divalent alkylene radical which may be interrupted by one or two divalent hetero atoms such as oxygen or sulphur</div> <div class="claim-text">R<sub>7</sub> represents an alkyl or haloalkyl radical</div> <div class="claim-text">R<sub>8</sub> represents an alkyl or haloalkyl radical or a hydrogen atom</div> <div class="claim-text">R<sub>9</sub> represents an alkyl radical or a hydrogen atom</div> <div class="claim-text">R<sub>10</sub> represents a phenyl or heteroaryl group optionally substituted with one or more halogen atoms or groups such as OH, --O-alkyl, S-alkyl, cyano or alkyl</div> <div class="claim-text">R<sub>11</sub> and R<sub>12</sub> represent, independently of each other, a hydrogen or halogen atom</div> <div class="claim-text">R<sub>13</sub> represents a halogen atom or a haloalkyl, haloalkoxy, S(O)<sub>q</sub> CF<sub>3</sub> or SF<sub>5</sub> group</div> <div class="claim-text">m, n, q and r represent, independently of each other, an integer equal to 0, 1 or 2</div> <div class="claim-text">X represents a trivalent nitrogen atom or a radical C--R<sub>12</sub>, the other three valency positions of the carbon atom forming part of the aromatic ring</div> <div class="claim-text">with the proviso that when R<sub>1</sub> is methyl, then R<sub>3</sub> is haloalkyl, R<sub>4</sub> is NH<sub>2</sub>, R<sub>11</sub> is Cl, R<sub>13</sub> is CF<sub>3</sub> and X is N.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="7" class="claim">
      <div class="claim-text">7. Composition according to claim 6, in which the compound of formula (I) is such that R<sub>1</sub> is CN, R<sub>3</sub> is haloalkyl, R<sub>4</sub> is NH<sub>2</sub>, R<sub>11</sub> and R<sub>12</sub> are, independently of each other, a halogen atom, and/or R<sub>13</sub> is haloalkyl.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="8" class="claim">
      <div class="claim-text">8. Composition according to claim 7, wherein X is C--R<sub>12</sub>.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="9" class="claim">
      <div class="claim-text">9. Composition according to claim 6, in which the compound of formula (I) is: 1-[2,6-Cl<sub>2</sub> 4-CF<sub>3</sub> phenyl] 3-CN 4-[SO-CF<sub>3</sub> ]5-NH<sub>2</sub> pyrazole, commonly known as Fipronil.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="10" class="claim">
      <div class="claim-text">10. Composition according to claim 6, characterized in that the compound (B) is a compound which mimics juvenile hormones or a chitin-synthesis inhibitor.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="11" class="claim">
      <div class="claim-text">11. Composition according to claim 10, characterized in that the compound of IGR type is chosen from methoprenes, pyriproxyfens, lufenuron, hydroprene, cryromazine and 1-(2,6-difluorobenzoyl)-3-(2-fluoro-4-(trifluoromethyl)phenylurea.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="12" class="claim">
      <div class="claim-text">12. Composition according to claim 10 wherein the compound which mimics juvenile hormones is selected from the group consisting of azadirachtin, diofenolan, fenoxycarb, hydroprene, kinoprene, methoprene, pyriproxyfen, tetrahydroazadirachtin, and 4-chloro-2-(2-chloro-2-methyl-propyl)-5-(6-iodo-3-pyridylmethoxy)-pyridizine-3(2H)-one.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="13" class="claim">
      <div class="claim-text">13. Composition according to claim 10 wherein the chitin-synthesis inhibitor is selected from the group consisting of chlorfluazuron, cyromazine, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, tebufenozide, teflubenzuron, triflumuron, 1-(2,6-difluorobenzoyl)-3-(2-fluoro-4- (trifluoromethyl)phenylurea,1-(2,6-difluoro-benzoyl)-3-(2-fluoro-4-(1,1,2,2-tetrafluoroethoxy)-phenylurea and 1-(2,6-difluoro-benzoyl)-3-(2-fluoro-4-trifluoro-methyl)phenylurea.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="14" class="claim">
      <div class="claim-text">14. Composition according to claim 6, characterized in that the proportions, by weight, of compounds (A) of formula (I) and of compounds of type (B) are between 80/20 and 20/80.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="15" class="claim">
      <div class="claim-text">15. Composition according to claim 6, characterized in that it contains a dose of from 0.1 to 40 mg/kg of compound (A) and from 0.1 to 40 mg/kg of compound (B).</div>
    </div>
    </div> <div class="claim-dependent"> <div num="16" class="claim">
      <div class="claim-text">16. Composition according to claim 15, characterized in that it contains a dose of from 1 to 20 mg/kg, in particular from 2 to 10 mg/kg, of compound (A) and from 1 to 30 mg/kg, in particular 2 to 20 mg/kg, of compound (B).</div>
    </div>
    </div> <div class="claim-dependent"> <div num="17" class="claim">
      <div class="claim-text">17. Composition according to claim 5, characterized in that the compound of formula (I) is such that R<sub>1</sub> is CN.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="18" class="claim">
      <div class="claim-text">18. Composition according to claim 5, characterized in that the compound of formula (I) is such that R<sub>13</sub> is haloalkyl.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="19" class="claim">
      <div class="claim-text">19. Composition according to claim 5, characterized in that the compound of formula (I) is such that R<sub>2</sub> is S(O)<sub>n</sub> R<sub>3</sub>, and R<sub>3</sub> is CF<sub>3</sub> or alkyl.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="20" class="claim">
      <div class="claim-text">20. Composition according to claim 5, characterized in that the compound of formula (I) is such that X is C--R<sub>12</sub> with R<sub>12</sub> being a halogen atom.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="21" class="claim">
      <div class="claim-text">21. Composition according to claim 5, in which the compound of formula (I) is such that R<sub>1</sub> is CN, R<sub>3</sub> is haloalkyl, R<sub>4</sub> is NH<sub>2</sub>, R<sub>11</sub> and R<sub>12</sub> are, independently of each other, a halogen atom, and/or R<sub>13</sub> is haloalkyl.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="22" class="claim">
      <div class="claim-text">22. Composition according to claim 5, in which the compound of formula (I) is: 1-[2,6-Cl<sub>2</sub> 4-CF<sub>3</sub> phenyl] 3-CN 4-[SO--CF<sub>3</sub> ]5-NH<sub>2</sub> pyrazole, commonly known as Fipronil.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="23" class="claim">
      <div class="claim-text">23. Composition according to claim 5, in which the compound of formula (I) is one of the following compounds:<div class="claim-text">1: 1-[2,6-Cl<sub>2</sub> 4-CF<sub>3</sub> phenyl] 3-CN 4-[S--CF<sub>3</sub> ]5-NH<sub>2</sub> pyrazole, commonly known as Fipronil</div> <div class="claim-text">2: 1-[2,6-Cl<sub>2</sub> 4-CF<sub>3</sub> phenyl] 3-CN 4-[SO--C<sub>2</sub> H<sub>5</sub> ]5-NH<sub>2</sub> pyrazole.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="24" class="claim">
      <div class="claim-text">24. Composition according to claim 5, characterized in that the compound (B) is a compound which mimics juvenile hormones or a chitin-synthesis inhibitor.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="25" class="claim">
      <div class="claim-text">25. Composition according to claim 24, characterized in that the compound of IGR type is chosen from methoprenes, pyriproxyfens, lufenuron, hydroprene, cryromazine and 1-(2,6-difluorobenzoyl)-3-(2-fluoro-4-(trifluoromethyl)phenylurea.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="26" class="claim">
      <div class="claim-text">26. Composition according to claim 24 wherein the compound which mimics juvenile hormones is selected from the group consisting of azadirachtin, diofenolan, fenoxycarb, hydroprene, kinoprene, methoprene, pyriproxyfen, tetrahydroazadirachtin, and 4-chloro-2-(2-chloro-2-methyl-propyl)-5-(6-iodo-3-pyridylmethoxy)-pyridizine-3(2H)-one.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="27" class="claim">
      <div class="claim-text">27. Composition according to claim 24 wherein the chitin-synthesis inhibitor is selected from the group consisting of chlorfluazuron, cyromazine, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, tebufenozide, teflubenzuron, triflumuron, 1-(2,6-difluorobenzoyl)-3-(2-fluoro-4-(trifluoromethyl)phenylurea,1-(2,6-difluoro-benzoyl)-3-(2-fluoro-4-(1,1,2,2-tetrafluoroethoxy)-phenylurea and 1-(2,6-difluoro-benzoyl)-3-(2-fluoro-4-trifluoro-methyl)phenylurea.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="28" class="claim">
      <div class="claim-text">28. Composition according to claim 5, characterized in that compound (B) is novaluron.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="29" class="claim">
      <div class="claim-text">29. Composition according to claim 5, characterized in that the proportions, by weight, of compounds (A) of formula (I) and of compounds of type (B) are between 80/20 and 20/80.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="30" class="claim">
      <div class="claim-text">30. Composition according to claim 5, characterized in that it also comprises a crystallization inhibitor (b), which is present in a proportion of from 1 to 20% (W/V).</div>
    </div>
    </div> <div class="claim-dependent"> <div num="31" class="claim">
      <div class="claim-text">31. Composition according to claim 30, characterized in that the crystallization inhibitor (b) is selected from the group consisting of:<div class="claim-text">polyvinylpyrrolidone, polyvinyl alcohols, copolymers of vinyl acetate and vinylpyrrolidone, polyethylene glycols, benzyl alcohol, mannitol, glycerol, sorbitol, polyoxyethylenated sorbitan esters; lecithin, sodium carboxymethylcellulose, methacrylates and other acrylic derivatives,</div> <div class="claim-text">anionic surfactants,</div> <div class="claim-text">cationic surfactants,</div> <div class="claim-text">amine salts of formula N<sup>+</sup> R'R"R'" in which the radicals R are optionally hydroxylated hydrocarbon radicals;</div> <div class="claim-text">nonionic surfactants;</div> <div class="claim-text">amphoteric surfactants; and</div> <div class="claim-text">a mixture of at least two of these crystallization inhibitors.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="32" class="claim">
      <div class="claim-text">32. Composition according to claim 31 wherein the anionic surfactant is selected from the group consisting of sodium, potassium or ammonium stearate or other alkaline stearates; calcium stearate; triethanolamine stearate; sodium abietate; sodium lauryl sulphate, sodium cetyl sulphate or other alkyl sulphates; sodium dodecylbenzenesulphonate, sodium dioctylsulphosuccinate; and fatty acids derived from coconut oil or other fatty acids.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="33" class="claim">
      <div class="claim-text">33. Composition according to claim 31 wherein the cationic surfactant is selected from the group consisting of water-soluble quaternary ammonium salts of formula N<sup>+</sup> R'R"R'"R"",Y<sup>-</sup> in which the radicals R are optionally hydroxylated hydrocarbon radicals and Y<sup>-</sup> is an anion of a strong acid; cetyltrimethyl-ammonium bromide; amine salts of formula N<sup>+</sup> R'R"R'" in which the radicals R are optionally hydroxylated hydrocarbon radicals; and octadecylamine hydrochloride.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="34" class="claim">
      <div class="claim-text">34. Composition according to claim 31 wherein the nonionic surfactant is selected from the group consisting of polysorbate 80, polyoxyethylenated alkyl ethers and other optionally polyoxyethylenated sorbitan esters; polyethylene glycol stearate, polyoxyethylenated derivatives of castor oil, polyglycerol esters, polyoxyethylenated fatty alcohols, polyoxyethylenated fatty acids, and copolymers of ethylene oxide and propylene oxide.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="35" class="claim">
      <div class="claim-text">35. Composition according to claim 31 wherein the amphoteric surfactant comprises substituted lauryl compounds of betaine.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="36" class="claim">
      <div class="claim-text">36. Composition according to claim 30, characterized in that it comprises a crystallization inhibitor couple formed by the combination of a film-forming agent of polymeric type and a surfactant.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="37" class="claim">
      <div class="claim-text">37. Composition according to claim 36, characterized in that the film-forming agent is selected from the group consisting of:<div class="claim-text">the various grades of polyvinylpyrrolidone,</div> <div class="claim-text">polyvinyl alcohols, and</div> <div class="claim-text">copolymers of vinyl acetate and vinyl pyrrolidone,<div class="claim-text">and in that the surfactant is selected from the group consisting of polyoxyethylenated sorbitan esters, various grades of polysorbate, and other non-ionic surfactants.</div> </div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="38" class="claim">
      <div class="claim-text">38. Composition according to claim 5, characterized in that it comprises an organic solvent (c) having a dielectric constant of between 10 and 35.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="39" class="claim">
      <div class="claim-text">39. Composition according to claim 38, characterized in that the organic solvent (c) is selected from the group consisting of acetone, acetonitrile, benzyl alcohol, butyldiglycol, dimethylacetamide, dimethylformamide, dipropylene glycol n-butyl ether, ethanol, isopropanol, methanol, ethylene glycol monoethyl ether, ethylene glycol monomethyl ether, monomethylacetamide, dipropylene glycol monomethyl ether, liquid polyoxyethylene glycols, propylene glycol, 2-pyrrolidone, diethylene glycol monoethyl ether, ethylene glycol, diethyl phthalate, and a mixture of at least two of these solvents.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="40" class="claim">
      <div class="claim-text">40. Composition according to claim 38, characterized in that it also comprises an organic co-solvent (d) having a boiling point below 100° C., and having a dielectric constant of between 10 and 40, which is miscible with water and/or with the solvent (c), this co-solvent being present in a co-solvent (d)/solvent (c) weight/weight (W/W) ratio of between 1/15 and 1/2.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="41" class="claim">
      <div class="claim-text">41. Composition according to claim 40, characterized in that the co-solvent (d) is chosen from absolute ethanol, isopropanol and methanol.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="42" class="claim">
      <div class="claim-text">42. Composition according to claim 1, wherein the composition is applied to a zone with a surface area of less than 10 cm<sup>2</sup>.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="43" class="claim">
      <div class="claim-text">43. Composition according to claim 40 wherein the composition is applied at two points between the animal's shoulders.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="44" class="claim">
      <div class="claim-text">44. Composition according to claim 5, characterized in that it contains a dose of from 0.1 to 40 mg/kg of compound (A) and from 0.1 to 40 mg/kg of compound (B).</div>
    </div>
    </div> <div class="claim-dependent"> <div num="45" class="claim">
      <div class="claim-text">45. Composition according to claim 44, characterized in that it contains a dose of from 1 to 20 mg/kg of compound (A) and from 1 to 30 mg/kg of compound (B).</div>
    </div>
    </div> <div class="claim-dependent"> <div num="46" class="claim">
      <div class="claim-text">46. Composition according to claim 5, characterized in that it affords protection for 2 to 3 months.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="47" class="claim">
      <div class="claim-text">47. Composition according to claim 5 wherein the mammals protected by the composition comprise cats and dogs.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="48" class="claim">
      <div class="claim-text">48. The composition according to claim 5, wherein the composition is a spot-on type.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="49" class="claim">
      <div class="claim-text">49. A method for controlling fleas and ticks on mammals over a long duration of time which comprises locally applying to the skin of said mammal a synergistically effective amount of a synergistic composition according to claim 5.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="50" class="claim">
      <div class="claim-text">50. The method according to claim 49, wherein the mammals are cats and dogs.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="51" class="claim">
      <div class="claim-text">51. The method according to claim 49 wherein, the dose of the composition is from 1 to 20 mg/kg of compound (A) and 1 to 30 mg/kg of compound (B).</div>
    </div>
    </div> <div class="claim-dependent"> <div num="52" class="claim">
      <div class="claim-text">52. The method according to claim 49, wherein it contains a dose of from 0.1 to 40 mg/kg of compound (A) and from 0.1 to 40 mg/kg of compound (B).</div>
    </div>
    </div> <div class="claim-dependent"> <div num="53" class="claim">
      <div class="claim-text">53. The method according to claim 49, wherein it contains a dose of from 1 to 20 mg/kg.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="54" class="claim">
      <div class="claim-text">54. The method of claim 49 wherein in the compound R<sub>1</sub> is CN.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="55" class="claim">
      <div class="claim-text">55. The method of claim 49 wherein in the compound R<sub>13</sub> is haloalkyl.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="56" class="claim">
      <div class="claim-text">56. The method of claim 49 wherein in the compound R<sub>13</sub> is CF<sub>3</sub>.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="57" class="claim">
      <div class="claim-text">57. The method of claim 49 wherein in the compound R<sub>2</sub> is S(O)<sub>n</sub> R<sub>3</sub>.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="58" class="claim">
      <div class="claim-text">58. The method of claim 49 wherein in the compound n=1 and R<sub>3</sub> is methyl, ethyl or CF<sub>3</sub>.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="59" class="claim">
      <div class="claim-text">59. The method of claim 49 wherein in the compound n=0 and R<sub>3</sub> is CF<sub>3</sub>.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="60" class="claim">
      <div class="claim-text">60. The method of claim 49 wherein in the compound X is C--R<sub>12</sub> and is a halogen atom.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="61" class="claim">
      <div class="claim-text">61. The method of claim 49 wherein in the compound R<sub>1</sub> is CN, and/or R<sub>3</sub> is haloalkyl, and/or R<sub>1</sub> is NH<sub>2</sub>, and/or R<sub>11</sub> and R<sub>12</sub> are, independently of each other, a halogen atom, and/or R<sub>13</sub> is haloalkyl.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="62" class="claim">
      <div class="claim-text">62. The method according to claim 49, wherein the synergistic composition comprises synergistic effective amounts of Fipronil and a compound which mimics juvenile hormones.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="63" class="claim">
      <div class="claim-text">63. The method according to claim 62, wherein the compound which mimics juvenile hormones is selected from the group consisting of azadirachtin, diofenolan, fenoxycarb, hydroprene, kinoprene, methoprene, pyriproxyfen, tetrahydroazadirachtin and 4-chloro-2-2- chloro-2-methyl-propyl)-5-(6-iodo-3-pyridylmethoxy) pyridizine-3(2H)-one.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="64" class="claim">
      <div class="claim-text">64. The method according to claim 62, wherein the compound which mimics juvenile hormones is methopren or pyriproxyfen.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="65" class="claim">
      <div class="claim-text">65. The method according to claim 62, wherein the compound which mimics juvenile hormones is methopren.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="66" class="claim">
      <div class="claim-text">66. The method according to claim 49, wherein the duration is two months.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="67" class="claim">
      <div class="claim-text">67. The method according to claim 49, wherein the duration is three months.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="68" class="claim">
      <div class="claim-text">68. The method according to claim 67, wherein the synergistic combination comprises synergistic effective amounts of Fipronil and methoprene.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="69" class="claim">
      <div class="claim-text">69. A method for distributing an active agent over a mammal's body and/or in the sebaceous glands of said mammal and thereby control fleas and ticks for a long period of time which comprises applying to the skin of said mammal a synergistic composition according to claim 5.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="70" class="claim">
      <div class="claim-text">70. A kit comprising, separately, in the same packaging, at least one container containing a synergist amount of a compound (A) according to claim 1 and at least one customary spot-on formulation adjuvant and at least one container containing a synergistic amount of a compound (B) according to claim 1 and at least one customary spot-on formulation adjuvant, and a notice specifying that the containers are to be used alternately with an interval.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES67510183" lang="EN" load-source="patent-office" class="description">
    <p>This application has been filed as a continuation-in-part of Ser. No.08/692,113 filed Aug. 5, 1996, now abandoned.</p>
    <p>The present invention relates to an improvement to the processes for controlling mammal fleas and in particular fleas on cats and dogs. The invention also relates to a novel composition for this use, based on a synergistic combination of parasiticides which are already known. Lastly, the invention relates to the use of such already-known parasiticides for the preparation of such a composition.</p>
    <p>A novel class of 1-N-arylpyrazole-based insecticides has been described in patents EP-A-295,217 and EP-A-352,944. The compounds of the classes defined in these patents are highly active, and one of these compounds 1-[2,6-Cl<sub>2</sub> 4-CF<sub>3</sub> phenyl]3-CN 4-[SO--CF<sub>3</sub> ]5-NH<sub>2</sub> pyrazole, whose common name is fipronil, has proven to be particularly effective not only against crop parasites but also against mammal ectoparasites and in particular, but not exclusively, fleas, ticks, flies and myiases.</p>
    <p>Compounds with an ovicidal and/or larvicidal effect on the immature stages of various ectoparasites are already known, for example from patent U.S. Pat. No. 5,439,924. Among these compounds are featured insect growth regulator compounds (IGR) which act either by blocking the development of the immature stages (eggs and larvae) into adult stages, or by inhibiting the synthesis of chitin.</p>
    <p>Patent FR-A-2,713,889 is moreover known, which generally describes the combination of at least one compound of IGR (insect growth regulator) type, comprising compounds with juvenile hormone activity and chitin synthesis inhibitors, with at least one of three N-aryldiazole compounds, in particular fipronil, to control many harmful insects belonging to very varied orders.</p>
    <p>The compositions may be used in very diverse forms, although the applications, for example veterinary, healthcare or plant-protection applications, for which these different forms are designed are not specified, nor are the parasites for which they are respectively intended.</p>
    <p>The only application which may be thought to be veterinary is associated with the example of the manufacture of a pesticidal collar which is a slow-release formulation.</p>
    <p>The invention proposes to improve the processes for controlling fleas in small mammals, and in particular in cats and dogs.</p>
    <p>The object of the invention is, in particular, to use already-known parasiticides in order to prepare a composition which is highly active against the fleas of these animals.</p>
    <p>Lastly, the object of the invention is a novel composition thus prepared and intended, in particular, to control fleas.</p>
    <p>For the purposes of the present invention, the term flea is understood to refer to all the usual or accidental species of parasitic flea of the order Siphonaptera, and in particular the species Ctenocephalides, in particular C. felis and C. canis, rat fleas (Xenopsylla cheopis) and human fleas (Pulex irritans).</p>
    <p>The very high efficacy of the process and of the composition according to the invention implies not only high immediate efficacy but also very long-lasting efficacy after the animal has been treated.</p>
    <p>The subject of the invention is a process for controlling the fleas of small mammals, and in particular cats and dogs, over a long period, characterized in that the animal is treated by locally depositing on the skin, preferably localized over a small surface area (spot-on application), in parasiticidally effective doses and proportions, on the one hand at least one compound (A) belonging to formula (I), ##STR1## in which:</p>
    <p>R<sub>1</sub> is CN or methyl or a halogen atom;</p>
    <p>R<sub>2</sub> is S(O)<sub>n</sub> R<sub>3</sub> or 4,5-dicyanoimidazol-2-yl or haloalkyl;</p>
    <p>R<sub>3</sub> is alkyl or haloalkyl;</p>
    <p>R<sub>4</sub> represents a hydrogen or halogen atom; or a member of a group consisting of NR<sub>5</sub> R<sub>6</sub>, S(O)<sub>m</sub> R<sub>7</sub>, C(O)R<sub>7</sub>, C(O)O--R<sub>7</sub>, alkyl, haloalkyl, OR<sub>8</sub> and --N═C(R<sub>9</sub>) (R<sub>10</sub>);</p>
    <p>R<sub>5</sub> and R<sub>6</sub> independently represent a hydrogen atom or an alkyl, haloalkyl, C(O)alkyl, alkoxycarbonyl or S(O)<sub>r</sub> --CF<sub>3</sub> radical; or R<sub>5</sub> and R<sub>6</sub> may together form a divalent alkylene radical which may be interrupted by one or two divalent hetero atoms such as oxygen or sulphur;</p>
    <p>R<sub>7</sub> represents an alkyl or haloalkyl radical;</p>
    <p>R<sub>8</sub> represents an alkyl or haloalkyl radical or a hydrogen atom;</p>
    <p>R<sub>9</sub> represents an alkyl radical or a hydrogen atom;</p>
    <p>R<sub>10</sub> represents a phenyl or heteroaryl group optionally substituted with one or more halogen atoms or a member of the group consisting of OH, --O-alkyl, S-alkyl, cyano and alkyl;</p>
    <p>R<sub>11</sub> and R<sub>12</sub> represent, independently of each other, a hydrogen or halogen atom, or possibly CN or NO<sub>2</sub> ;</p>
    <p>R<sub>13</sub> represents a halogen atom or a haloalkyl, haloalkoxy, S(O)<sub>q</sub> CF<sub>3</sub> or SF<sub>5</sub> group;</p>
    <p>m, n, q and r represent, independently of each other, an integer equal to 0, 1 or 2</p>
    <p>X represents a trivalent nitrogen atom or a radical C--R<sub>12</sub>, the other three valency positions of the carbon atom forming part of the aromatic ring</p>
    <p>with the proviso that when R<sub>1</sub> is methyl, either R<sub>3</sub> is haloalkyl, R<sub>4</sub> is NH<sub>2</sub>, R<sub>11</sub> is Cl, R<sub>13</sub> is CF<sub>3</sub> and X is N; or R<sub>2</sub> is 4,5-dicyanoimidazol-2-yl, R<sub>4</sub> is Cl, R<sub>11</sub> is Cl, R<sub>13</sub> is CF<sub>3</sub> and X is ═C--Cl;</p>
    <p>and, on the other hand at least one compound (B), of IGR (insect growth regulator) type, in a fluid vehicle which is acceptable for the animal and suitable for local application on the skin.</p>
    <p>Preferably, one uses at least one compound (A) belonging to the formula (I) in which:</p>
    <p>R<sub>1</sub> is CN or methyl</p>
    <p>R<sub>2</sub> is S(O)<sub>n</sub> R<sub>3</sub> </p>
    <p>R<sub>3</sub> is alkyl or haloalkyl</p>
    <p>R<sub>4</sub> represents a hydrogen or halogen atom; or a radical NR<sub>5</sub> R<sub>6</sub>, S(O)<sub>m</sub> R<sub>7</sub>, C(O)R<sub>7</sub>, alkyl, haloalkyl or OR<sub>8</sub> or a radical --N═C(R<sub>9</sub>) (R<sub>10</sub>)</p>
    <p>R<sub>5</sub> and R<sub>6</sub> independently represent a hydrogen atom or an alkyl, haloalkyl, C(O)alkyl or S(O)<sub>r</sub> ---CF<sub>3</sub> radical; or R<sub>5</sub> and R<sub>6</sub> may together form a divalent alkylene radical which may be interrupted by one or two divalent hetero atoms such as oxygen or sulphur</p>
    <p>R<sub>7</sub> represents an alkyl or haloalkyl radical</p>
    <p>R<sub>8</sub> represents an alkyl or haloalkyl radical or a hydrogen atom</p>
    <p>R<sub>9</sub> represents an alkyl radical or a hydrogen atom</p>
    <p>R<sub>10</sub> represents a phenyl or heteroaryl group optionally substituted with one or more halogen atoms or groups such as OH, --O-alkyl, S-alkyl, cyano or alkyl</p>
    <p>R<sub>11</sub> and R<sub>12</sub> represent, independently of each other, a hydrogen or halogen atom</p>
    <p>R<sub>13</sub> represents a halogen atom or a haloalkyl, haloalkoxy, S(O)<sub>q</sub> CF<sub>3</sub> or SF<sub>5</sub> group</p>
    <p>m, n, q and r represent, independently of each other, an integer equal to 0, 1 or 2</p>
    <p>X represents a trivalent nitrogen atom or a radical C--R<sub>12</sub>, the other three valency positions of the carbon atom forming part of the aromatic ring</p>
    <p>with the proviso that when R<sub>1</sub> is methyl, then R<sub>3</sub> is haloalkyl, R<sub>4</sub> is NH<sub>2</sub>, R<sub>11</sub> is Cl, R<sub>13</sub> is CF<sub>3</sub> and X is N.</p>
    <p>Compounds of formula (I) in which R<sub>1</sub> is CN will be selected most particularly. Compounds in which R<sub>2</sub> is S(O)<sub>n</sub> R<sub>3</sub>, preferably with n=1, R<sub>3</sub> preferably being CF<sub>3</sub> or alkyl, for example methyl or ethyl, or alternatively n=0, R<sub>3</sub> preferably being CF<sub>3</sub>, as well as those in which X=C--R<sub>12</sub>, R<sub>12</sub> being a halogen atom, will also be selected. Compounds in which R<sub>11</sub> is a halogen atom and those in which R<sub>13</sub> is haloalkyl, preferably CF<sub>3</sub>, are also preferred. Within the context of the present invention, compounds which combine two or more of these characteristics will advantageously be selected.</p>
    <p>A preferred class of compounds of formula (I) consists of compounds such that R<sub>1</sub> is CN, R<sub>3</sub> is haloalkyl, R<sub>4</sub> is NH<sub>2</sub>, R<sub>11</sub> and R<sub>12</sub> are, independently of each other, a halogen atom, and/or R<sub>13</sub> is haloalkyl. Preferably also, X is C--R<sub>12</sub>.</p>
    <p>In these compounds, R<sub>3</sub> preferably represents CF<sub>3</sub> or ethyl.</p>
    <p>In the present invention, the alkyl radicals may contain generally from 1 to 6 carbon atoms. The ring formed by the divalent alkylene radical representing R<sub>5</sub> and R<sub>6</sub>, as well as the nitrogen atom to which R<sub>5</sub> and R<sub>6</sub> are attached, may be generally a 5-, 6- or 7-membered ring.</p>
    <p>A compound of formula (I) which is most particularly preferred in the invention is 1-[2,6-Cl<sub>2</sub> 4-CF<sub>3</sub> phenyl]3-CN 4-[SO--CF<sub>3</sub> ] 5-NH<sub>2</sub> pyrazole, the common name of which is fipronil.</p>
    <p>The two compounds which differ from the above by the following characteristics:</p>
    <p>1- n=0, R<sub>3</sub> =CF<sub>3</sub> </p>
    <p>2- n=1, R<sub>3</sub> =ethyl.</p>
    <p>may also be mentioned.</p>
    <p>Among the compounds (B), mention may be made in particular of compounds which mimic juvenile hormones, in particular:</p>
    <p>azadirachtin--Agridyne</p>
    <p>diofenolan (Ciba Geigy)</p>
    <p>fenoxycarb (Ciba Geigy)</p>
    <p>hydroprene (Sandoz)</p>
    <p>kinoprene (Sandoz)</p>
    <p>methoprene (Sandoz)</p>
    <p>pyriproxyfen (Sumitomo/Mgk)</p>
    <p>tetrahydroazadirachtin (Agridyne)</p>
    <p>4-chloro-2-(2-chloro-2-methylpropyl)-5-(6-iodo-3-pyridylmethoxy)pyridizin-3(2H)-one</p>
    <p>and chitin-synthesis inhibitors, in particular:</p>
    <p>chlorfluazuron (Ishihara Sangyo)</p>
    <p>cyromazine (Ciba Geigy)</p>
    <p>diflubenzuron (Solvay Duphar)</p>
    <p>fluazuron (Ciba Geigy)</p>
    <p>flucycloxuron (Solvay Duphar)</p>
    <p>flufenoxuron (Cyanamid)</p>
    <p>hexaflumuron (Dow Elanco)</p>
    <p>lufenuron (Ciba Geigy)</p>
    <p>tebufenozide (Rohm &amp; Haas)</p>
    <p>teflubenzuron (Cyanamid)</p>
    <p>triflumuron (Bayer)</p>
    <p>these compounds being defined by their international common name (The Pesticide Manual, 10th edition, 1994, Ed. Clive Tomlin, Great Britain).</p>
    <p>As chitin-synthesis inhibitors, mention may also be made of compounds such as 1-(2,6-difluorobenzoyl)-3-(2-fluoro-4-(trifluoromethyl)phenylurea, 1-(2,6-difluorobenzoyl)-3-(2-fluoro-4-(1,1,2,2-tetrafluoroethoxy)phenylurea and 1-(2,6-difluorobenzoyl)-3-(2-fluoro-4-trifluoro-methyl)phenylurea.</p>
    <p>Novaluron (Isagro, Italian company) may also be mentioned as a compound (B).</p>
    <p>The preferred compounds (B) are methoprenes, pyriproxyfens, hydroprene, cyromazine, lufenuron and 1-(2,6-difluorobenzoyl)-3-(2-fluoro-4-(trifluoromethyl)phenylurea.</p>
    <p>Another preferred compound (B) is again novaluron.</p>
    <p>It is preferable for the administration of the two types of compound to be concomitant and preferably simultaneous.</p>
    <p>It is preferable for the treatment according to the invention to be carried out every two or, preferably, every three months on cats and dogs.</p>
    <p>Preferably, the treatment is carried out so as to administer to the animal a dose of from 0.1 to 40 and in particular from 1 to 20 mg/kg of derivative (A) and a dose of from 0.1 to 40 and in particular 1 to 30 mg/kg of compound (B).</p>
    <p>The preferred doses are from 5 to 15 mg/kg for compound (A) and from 0.5 to 15 mg/kg for the preferred compounds (B), or 10 to 20 mg/kg for the other compounds (B).</p>
    <p>In another embodiment of the process according to the invention, compounds (A) and (B) may be applied in a distinct and separate manner over time. In this case, it is preferred to alternate the applications with an interval, for example of one month between two applications, the first application preferably being made with compound (A).</p>
    <p>It is understood that the dosage values which are thus indicated are average values which may vary within a wide range, since, in practice, a formulation having defined doses of compound (A) of 1-N-phenylpyrazole-type derivative and of compound (B) will be administered to animals having relatively different weights. Consequently, the doses actually applied are often smaller or larger by a factor which may be up to 2, 3 or 4 relative to the preferred dose, without entailing any toxic risk for the animal in the case of an overdose, and while at the same time retaining real efficacy, possibly of shorter duration, in the case of an underdose.</p>
    <p>The object of this process is non-therapeutic and relates in particular to the cleaning of animal hairs and skin by elimination of the parasites which are present, as well as their residues and dejections. The treated animals thus have hair which is more pleasant to look at and to feel. This also allows one to avoid the development of fleas in the house.</p>
    <p>The invention also relates to such a process for therapeutic purposes, which is intended to treat and prevent parasitoses having pathogenic consequences.</p>
    <p>In accordance with the present invention, the process described above may also be used to control ectoparasites, in particular ticks.</p>
    <p>The subject of the invention is also a composition, in particular one for controlling fleas on small mammals, characterized in that it includes, on the one hand, at least one compound (A) of formula (I) as defined above, and, on the other hand, at least one compound (B) defined above, in doses and proportions which have parasiticidal efficacy on fleas, in a fluid vehicle which is acceptable for the animal and convenient for local application to the skin, preferably localized over a small surface area.</p>
    <p>Preferably, in formula (I);</p>
    <p>R<sub>1</sub> is CN or methyl</p>
    <p>R<sub>2</sub> is S(O)<sub>n</sub> R<sub>3</sub> </p>
    <p>R<sub>3</sub> is alkyl or haloalkyl</p>
    <p>R<sub>4</sub> represents a hydrogen or halogen atom; or a radical NR<sub>5</sub> R<sub>6</sub>, S(O)<sub>m</sub> R<sub>7</sub>, C(O)R<sub>7</sub>, alkyl, haloalkyl or OR<sub>8</sub> or a radical --N═C(R<sub>9</sub>) (R<sub>10</sub>)</p>
    <p>R<sub>5</sub> and R<sub>6</sub> independently represent a hydrogen atom or an alkyl, haloalkyl, C(O)alkyl or S(O)<sub>r</sub> --CF<sub>3</sub> radical; or R<sub>5</sub> and R<sub>6</sub> may together form a divalent alkylene radical which may be interrupted by one or two divalent hetero atoms such as oxygen or sulphur</p>
    <p>R<sub>7</sub> represents an alkyl or haloalkyl radical</p>
    <p>R<sub>8</sub> represents an alkyl or haloalkyl radical or a hydrogen atom</p>
    <p>R<sub>9</sub> represents an alkyl radical or a hydrogen atom</p>
    <p>R<sub>10</sub> represents a phenyl or heteroaryl group optionally substituted with one or more halogen atoms or groups such as OH, --O-alkyl, S-alkyl, cyano or alkyl</p>
    <p>R<sub>11</sub> and R<sub>12</sub> represent, independently of each other, a hydrogen or halogen atom</p>
    <p>R<sub>13</sub> represents a halogen atom or a haloalkyl, haloalkoxy, S(O)<sub>q</sub> CF<sub>3</sub> or SF<sub>5</sub> group</p>
    <p>m, n, q and r represent, independently of each other, an integer equal to 0, 1 or 2</p>
    <p>X represents a trivalent nitrogen atom or a radical C--R<sub>12</sub>, the other three valency positions of the carbon atom forming part of the aromatic ring</p>
    <p>with the proviso that when R<sub>1</sub> is methyl, then R<sub>3</sub> is haloalkyl, R<sub>4</sub> is NH<sub>2</sub>, R<sub>11</sub> is Cl, R<sub>13</sub> is CF<sub>3</sub> and X is N.</p>
    <p>Compounds of formula (I) in which R<sub>1</sub> is CN will be selected most particularly. Compounds in which R<sub>2</sub> is S(O)<sub>n</sub> R<sub>3</sub>, preferably with n=1, R<sub>3</sub> preferably being CF<sub>3</sub> or alkyl, for example methyl or ethyl, or alternatively n=0, R<sub>3</sub> preferably being CF<sub>3</sub>, as well as those in which X=C--R<sub>12</sub>, R<sub>12</sub> being a halogen atom, will also be selected. Compounds in which R<sub>11</sub> is a halogen atom and those in which R<sub>13</sub> is haloalkyl, preferably CF<sub>3</sub>, are also preferred. Within the context of the present invention, compounds which combine two or more of these characteristics will advantageously be selected.</p>
    <p>A preferred class of compounds of formula (I) consists of compounds such that R<sub>1</sub> is CN, R<sub>3</sub> is haloalkyl, R<sub>4</sub> is NH<sub>2</sub>, R<sub>11</sub> and R<sub>12</sub> are, independently of each other, a halogen atom, and/or R<sub>13</sub> is haloalkyl.</p>
    <p>In these compounds, R<sub>3</sub> preferably represents CF<sub>3</sub> or ethyl.</p>
    <p>A compound of formula (I) which is most particularly preferred in the invention is 1-[2,6-Cl<sub>2</sub> 4-CF<sub>3</sub> phenyl]3-CN 4-[SO--CF<sub>3</sub> ] 5-NH<sub>2</sub> pyrazole.</p>
    <p>The two compounds which differ from the above by the following characteristics:</p>
    <p>1- n=0, R<sub>3</sub> =CF<sub>3</sub> </p>
    <p>2- n=1, R<sub>3</sub> =ethyl</p>
    <p>may also be mentioned.</p>
    <p>The compounds of formula (I) may be prepared according to one or other of the processes described in patent applications WO-A-87/3781, 93/6089, 94/21606 or European patent application EP-A-0,295,117, or any other process which falls within the competence of a specialist skilled in the art of chemical synthesis. For the chemical preparation of the products of the invention, a person skilled in the art is considered as having at his disposal, inter alia, all of the contents of "Chemical Abstracts" and the documents cited therein.</p>
    <p>Among the compounds of IGR type listed above, methoprenes, pyriproxyfens, hydroprene, cyromazine, lufenuron and 1-(2,6-difluorobenzoyl)-3-(2-fluoro-4-(trifluoromethyl)phenylurea are preferred.</p>
    <p>Novaluron is also preferred.</p>
    <p>The proportions, by weight, of compounds of formula (I) and of compound (B) are preferably between 80/20 and 20/80.</p>
    <p>The fluid vehicle may be simple or complex and it is adapted to the route and mode of administration selected.</p>
    <p>The compositions for spot-on application can advantageously comprise:</p>
    <p>b) a crystallization inhibitor, in particular one which is present in a proportion of from 1 to 20% (W/V), preferably from 5 to 15%, this inhibitor satisfying the test according to which: 0.3 ml of a solution A comprising 10% (W/V) of the compound of formula (I) in the solvent defined in c) below, along with 10% of this inhibitor, are deposited on a glass slide at 20° C. for 24 hours, after which it is observed with the naked eye that there are few or no crystals, in particular fewer than 10 crystals, preferably 0 crystals on the glass slide,</p>
    <p>c) an organic solvent having a dielectric constant of between 10 and 35, preferably of between 20 and 30, the content of this solvent c) in the overall composition preferably representing the difference to make the composition up to 100%,</p>
    <p>d) an organic cosolvent having a boiling point of below 100° C., preferably of below 80° C., and having a dielectric constant of between 10 and 40, preferably of between 20 and 30; this cosolvent may advantageously be present in the composition in a d)/c) weight/weight (W/W) ratio of between 1/15 and 1/2. The solvent is volatile, so as to serve in particular as a drying promoter, and is miscible with water and/or with the solvent c).</p>
    <p>Although this is not preferred, the composition for spot-on application may optionally comprise water, in particular in a proportion of from 0 to 30% (volume per unit volume, V/V), in particular from 0 to 5%.</p>
    <p>The composition for spot-on application may also comprise an antioxidant intended to inhibit air-oxidation, this agent being present in particular in a proportion of from 0.005 to 1% (W/V), preferably from 0.01 to 0.05%.</p>
    <p>The compositions according to the invention intended for pets, in particular cats and dogs, are generally applied by being deposited onto the skin ("spot-on" or "pour-on" application); this is generally a localized application over a surface area of less than 10 cm<sup>2</sup>, especially of between 5 and 10 cm<sup>2</sup>, in particular at two points and preferably localized between the animal's shoulders. Once deposited, the composition diffuses, in particular over the animal's entire body, and then dries without crystallizing or modifying the appearance (in particular absence of any whitish deposit or dusty appearance) or the feel of the fur.</p>
    <p>The compositions for spot-on application according to the invention are particularly advantageous owing to their efficacy, their speed of action and the pleasant appearance of the animal's fur after application and drying.</p>
    <p>As organic solvent c) which can be used in the invention, mention may be made in particular of: acetone, acetonitrile, benzyl alcohol, butyl diglycol, dimethylacetamide, dimethylformamide, dipropylene glycol n-butyl ether, ethanol, isopropanol, methanol, ethylene glycol monoethyl ether, ethylene glycol monomethyl ether, monomethylacetamide, dipropylene glycol monomethyl ether, liquid polyoxyethylene glycols, propylene glycol, 2-pyrrolidone, in particular N-methylpyrrolidone, diethylene glycol monoethyl ether, ethylene glycol and diethyl phthalate, or a mixture of at least two of these solvents.</p>
    <p>As crystallization inhibitor b) which can be used in the invention, mention may be made in particular of:</p>
    <p>polyvinylpyrrolidone, polyvinyl alcohols, copolymers of vinyl acetate and vinylpyrrolidone, polyethylene glycols, benzyl alcohol, mannitol, glycerol, sorbitol, polyoxyethylenated sorbitan esters; lecithin, sodium carboxymethylcellulose, acrylic derivatives such as methacrylates and the like,</p>
    <p>anionic surfactants such as alkaline stearates, in particular sodium, potassium or ammonium stearate; calcium stearate; triethanolamine stearate; sodium abietate; alkyl sulphates, in particular sodium lauryl sulphate and sodium cetyl sulphate; sodium dodecylbenzenesulphonate, sodium dioctylsulphosuccinate; fatty acids, in particular those derived from coconut oil,</p>
    <p>cationic surfactants such as water-soluble quaternary ammonium salts of formula N<sup>+</sup> R'R"R'"R"",Y<sup>-</sup> in which the radicals R are optionally hydroxylated hydrocarbon radicals and Y<sup>-</sup> is an anion of a strong acid such as the halide, sulphate and sulphonate anions; cetyltrimethylammonium bromide is among the cationic surfactants which can be used,</p>
    <p>amine salts of formula N<sup>+</sup> R'R"R'" in which the radicals R are optionally hydroxylated hydrocarbon radicals; octadecylamine hydrochloride is among the cationic surfactants which can be used,</p>
    <p>nonionic surfactants such as optionally polyoxyethylenated sorbitan esters, in particular polysorbate 80, polyoxyethylenated alkyl ethers; polyethylene glycol stearate, polyoxyethylenated derivatives of castor oil, polyglycerol esters, polyoxyethylenated fatty alcohols, polyoxyethylenated fatty acids, copolymers of ethylene oxide and propylene oxide,</p>
    <p>amphoteric surfactants such as substituted lauryl compounds of betaine,</p>
    <p>or preferably a mixture of at least two of these crystallization inhibitors.</p>
    <p>In a particularly preferred manner, a crystallization inhibitor couple, namely the combination of a film-forming agent of polymeric type and a surfactant, will be used. These agents will be chosen in particular from the compounds mentioned as crystallization inhibitor b).</p>
    <p>Among the film-forming agents of polymeric type which are particularly advantageous, mention may be made of:</p>
    <p>the various grades of polyvinylpyrrolidone,</p>
    <p>polyvinyl alcohols, and</p>
    <p>copolymers of vinyl acetate and vinylpyrrolidone.</p>
    <p>As regards the surfactants, mention will be made most particularly of nonionic surfactants, preferably polyoxyethylenated sorbitan esters and in particular the various grades of polysorbate, for example polysorbate 80.</p>
    <p>The film-forming agent and the surfactant may be incorporated, in particular, in similar or identical amounts within the limit of the total amounts of crystallization inhibitor mentioned elsewhere.</p>
    <p>The couple thus produced ensures the objectives of absence of crystallization on the hairs and maintenance of the cosmetic appearance of the coat in a note-worthy manner, that is to say without any tendency towards stickiness or to a sticky appearance, despite the high concentration of active material.</p>
    <p>As cosolvent d), mention may be made in particular of: absolute ethanol, isopropanol, methanol.</p>
    <p>As antioxidant, standard agents are used in particular, such as: butylhydroxyanisole, butylhydroxytoluene, ascorbic acid, sodium metabisulphite, propyl gallate and sodium thiosulphate, or a mixture of not more than two of these agents.</p>
    <p>The compositions for spot-on application according to the invention are usually prepared by simple mixing of the constituents as defined earlier; advantageously, to begin with, the active material is mixed in the main solvent and the other ingredients or adjuvants are then added.</p>
    <p>The volume applied may be from about 0.3 to 1 ml, preferably about 0.5 ml for cats, and from about 0.3 to 3 ml for dogs, according to the weight of the animal.</p>
    <p>In a particularly preferred manner, the composition according to the invention may be in the form of a concentrated emulsion, suspension or solution for spot-on application to a small area of the animal's skin, generally between the two shoulders (spot-on type solution). In a clearly less preferred manner, forms of solution or suspension to be sprayed, forms of solution, suspension or emulsion to be poured or spread onto the animal (pour-on type solution) an oil, a cream, an ointment or any other fluid formulation for topical administration may be provided.</p>
    <p>Advantageously, the ready-to-use composition contains a dose of from 0.1 to 40 mg/kg of compound (A) of formula (I) and 0.1 to 40 mg/kg of compound (B).</p>
    <p>Preferably, a ready-to-use dosed formulation, in particular one for spot-on application, contains 1 to 20 mg/kg, preferably 2 to 10 mg/kg of compound (A), in particular fipronil, and from 1 to 30 mg/kg, preferably 2 to 10 mg/kg, of preferred compound (B) or 10 to 20 mg/kg of other compound (B).</p>
    <p>Advantageously, ready-to-use compositions dosed for 1-10, 10-20 and 20-40 kg animals respectively may be provided.</p>
    <p>In another embodiment, provided for separate application over time, a composition may be made in the form of a kit separately combining, in the same packaging, a composition containing a compound of formula (I), in particular fipronil, and a composition containing compound (B), preferably pyriproxyfen, each of the compositions including a vehicle which allows it to be applied onto the skin.</p>
    <p>Preferably, each of the two compositions is provided for local spot-on application and, preferably, a container containing just the dose required is provided for each application.</p>
    <p>Thus, for example, a kit may contain, in a package, three containers each containing a single dose of composition of compound (A) and three containers each containing a single dose of composition of compound (B), the containers (A) being distinguished from the containers (B) by markings, shapes or colours, as well as a notice specifying that the containers (A) and (B) must be used alternately with an interval, for example, of one month, and starting, for example, with a container (A).</p>
    <p>The compositions according to the invention, in particular those for spot-on application, have proven to be extremely effective for the very long-lasting treatment of fleas on mammals, and in particular small mammals such as cats and dogs.</p>
    <p>The discovery that the compound (A), such as fipronil, dissolves in the sebum so as to cover the entire animal and becomes concentrated in the sebaceous glands, from which it is gradually released over a very long period, is a plausible explanation of this long-lasting efficacy for these compositions, and could perhaps also explain the long-lasting action of the associated compound (B).</p>
    <p>They also have a certain efficacy against other parasitic insects and, in particular, ticks, and it is understood that the application of the composition according to the invention may be extended to the treatment of ectoparasites, or even endoparasites for which the composition proves to have real utility capable of being obtained practically, according to the criteria of the veterinary art.</p>
    <p>Thus, for example, a composition based on fipronil and fluazuron may also be used in particular against ticks.</p>
    <p>Where appropriate, the composition according to the invention may also comprise another insecticide, and in particular imidaclopride.</p>
    <p>The subject of the invention is also the use of at least one compound (A) of formula (I) and of at least one compound (B) of IGR type, as defined above, for the preparation of a composition as defined above.</p>
    <p>Other advantages and characteristics of the invention will become apparent on reading the description which follows, which is given by way of non-limiting example.</p>
    <p>The composition preparation example which follows includes, as compound (A) of formula (I), the compound known as fipronil.</p>
    <p>By way of example to prepare a composition for local application to the skin according to the invention, the following components may advantageously be mixed together:</p>
    <p>a1--compound (B) in a proportion of from 1 to 20% (percentage as a weight per unit volume W/V)</p>
    <p>a2--compound (A) of formula (I), in a proportion of from 1 to 20%, preferably 5 to 15% (percentage as a weight per unit volume W/V).</p>
    <p>By way of example, the compositions according to the invention comprise the following concentrations (W/V) of compounds (A) and (B) in a liquid medium comprising a representative of each of the components b, c and d. The total volume is 1 ml.</p>
    <heading>EXAMPLE 1</heading> <p>fipronil 10%</p>
    <p>pyriproxyfen 5%</p>
    <heading>EXAMPLE 2</heading> <p>fipronil 5%</p>
    <p>pyriproxyfen 5%</p>
    <heading>EXAMPLE 3</heading> <p>fipronil 5%</p>
    <p>pyriproxyfen 20%</p>
    <heading>EXAMPLE 4</heading> <p>fipronil 10%</p>
    <p>methoprene 30%</p>
    <heading>EXAMPLE 5</heading> <p>fipronil 10%</p>
    <p>1-(2,6-difluorobenzoyl)-3-(2-fluoro-4-trifluoromethyl)phenylurea 5%.</p>
    <p>Cats are infested with 100 fleas each, and are then reinfested every 10 days. Concomitant with the first manifestation, they receive a local skin application of 0.1 ml/kg of the composition according to Example 1. Two months after the treatment and ten days after the last infestation, no fleas are detected and the eggs collected are found to be non-viable.</p>
    <p>Dogs treated according to the same procedure with compositions according to Examples 1 and 2 show the same efficacy of treatment two months after application of the composition.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5516787">US5516787</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 19, 1994</td><td class="patent-data-table-td patent-date-value">May 14, 1996</td><td class="patent-data-table-td ">Sumitomo Chemical Company, Limited</td><td class="patent-data-table-td ">An n-aryl pyrazole compound and a chrysanthemate</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5567429">US5567429</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 21, 1994</td><td class="patent-data-table-td patent-date-value">Oct 22, 1996</td><td class="patent-data-table-td ">Sumitomo Chemical Company, Limited</td><td class="patent-data-table-td ">Pest controlling composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5629334">US5629334</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 12, 1995</td><td class="patent-data-table-td patent-date-value">May 13, 1997</td><td class="patent-data-table-td ">Sumitomo Chemical Company, Limited</td><td class="patent-data-table-td ">Synergistic effect of pyrethroid and n-aryldiazole compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1998025466A1?cl=en">WO1998025466A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 9, 1997</td><td class="patent-data-table-td patent-date-value">Jun 18, 1998</td><td class="patent-data-table-td ">Bettarini Franco</td><td class="patent-data-table-td ">Compositions for the systemic control of parasites of warm-blooded animals</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6313157">US6313157</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 13, 1999</td><td class="patent-data-table-td patent-date-value">Nov 6, 2001</td><td class="patent-data-table-td ">Rhone-Poulenc Agro</td><td class="patent-data-table-td ">Orally adiminstering 1-arylpyrazole compound such as 5-amino-3-cyano-1-(2, 6-dichloro-4-pentafluorosulfenylphenyl)-4-trifluoromethylsulfi nylpyrazole for controlling fleas in animals</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6395765">US6395765</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 25, 1996</td><td class="patent-data-table-td patent-date-value">May 28, 2002</td><td class="patent-data-table-td ">Merial</td><td class="patent-data-table-td ">Parasiticides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6566388">US6566388</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 29, 1995</td><td class="patent-data-table-td patent-date-value">May 20, 2003</td><td class="patent-data-table-td ">Rhone-Poulenc Agrochimie</td><td class="patent-data-table-td ">Using a phenyl substituted pyrazole compound</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6716442">US6716442</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 25, 1998</td><td class="patent-data-table-td patent-date-value">Apr 6, 2004</td><td class="patent-data-table-td ">Merial</td><td class="patent-data-table-td ">Cyclic applying of pesticides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6828275">US6828275</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 21, 2003</td><td class="patent-data-table-td patent-date-value">Dec 7, 2004</td><td class="patent-data-table-td ">Bayer Aktiengesellschaft</td><td class="patent-data-table-td ">Synergistic insecticide mixtures</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6867229">US6867229</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 8, 2002</td><td class="patent-data-table-td patent-date-value">Mar 15, 2005</td><td class="patent-data-table-td ">Merial</td><td class="patent-data-table-td ">Antiparasitic composition for the treatment and protection of pets</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7132448">US7132448</a></td><td class="patent-data-table-td patent-date-value">Aug 3, 2004</td><td class="patent-data-table-td patent-date-value">Nov 7, 2006</td><td class="patent-data-table-td ">The Hartz Mountain Corporation</td><td class="patent-data-table-td ">High concentration topical insecticide containing insect growth regulator</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7262214">US7262214</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 26, 2003</td><td class="patent-data-table-td patent-date-value">Aug 28, 2007</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">1-N-arylpyrazole derivatives in prevention of arthropod-borne and mosquito-borne diseases</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7345092">US7345092</a></td><td class="patent-data-table-td patent-date-value">Aug 3, 2004</td><td class="patent-data-table-td patent-date-value">Mar 18, 2008</td><td class="patent-data-table-td ">Summit Vetpharm, Llc</td><td class="patent-data-table-td ">A first insecticide for killing fleas is packaged separately from a second insecticide for killing ticks and one of the insecticides is packaged with an insect growth regulator; enhanced insecticidal activity against fleas and ticks while advantageously minimizing the total amount of insecticide needed</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7354595">US7354595</a></td><td class="patent-data-table-td patent-date-value">May 9, 2005</td><td class="patent-data-table-td patent-date-value">Apr 8, 2008</td><td class="patent-data-table-td ">Summit Vetpharm, Llc</td><td class="patent-data-table-td ">Formulated by dissolving an insecticidably effective amount of dinotefuran in a solvent component containing ethyl lactate to dissolve said dinotefuran; kill fleas, flea eggs, and flea larvae</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7368435">US7368435</a></td><td class="patent-data-table-td patent-date-value">Sep 7, 2005</td><td class="patent-data-table-td patent-date-value">May 6, 2008</td><td class="patent-data-table-td ">Summit Vetpharm, Llc</td><td class="patent-data-table-td ">Topical endoparasiticide and ectoparasiticide formulations</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7531186">US7531186</a></td><td class="patent-data-table-td patent-date-value">Feb 20, 2004</td><td class="patent-data-table-td patent-date-value">May 12, 2009</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Topical formulations comprising 1-N-arylpyrazole derivatives and amitraz</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7759381">US7759381</a></td><td class="patent-data-table-td patent-date-value">Jul 3, 2007</td><td class="patent-data-table-td patent-date-value">Jul 20, 2010</td><td class="patent-data-table-td ">Aventis Agriculture</td><td class="patent-data-table-td ">1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7906535">US7906535</a></td><td class="patent-data-table-td patent-date-value">Apr 27, 2007</td><td class="patent-data-table-td patent-date-value">Mar 15, 2011</td><td class="patent-data-table-td ">Summit Vetpharm, Llc</td><td class="patent-data-table-td ">High concentration topical insecticides containing pyrethroids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7960426">US7960426</a></td><td class="patent-data-table-td patent-date-value">Feb 3, 2009</td><td class="patent-data-table-td patent-date-value">Jun 14, 2011</td><td class="patent-data-table-td ">Pfizer Limited</td><td class="patent-data-table-td ">Substituted arylpyrazoles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8028661">US8028661</a></td><td class="patent-data-table-td patent-date-value">Sep 16, 2009</td><td class="patent-data-table-td patent-date-value">Oct 4, 2011</td><td class="patent-data-table-td ">Centers For Disease Control And Prevention</td><td class="patent-data-table-td ">Method for applying chemicals to rodents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8084486">US8084486</a></td><td class="patent-data-table-td patent-date-value">Apr 19, 2011</td><td class="patent-data-table-td patent-date-value">Dec 27, 2011</td><td class="patent-data-table-td ">Pfizer Limited</td><td class="patent-data-table-td ">Substituted arylpyrazoles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8242161">US8242161</a></td><td class="patent-data-table-td patent-date-value">Apr 8, 2009</td><td class="patent-data-table-td patent-date-value">Aug 14, 2012</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Topical formulations comprising 1-N-arylpyrazole derivatives and amitraz</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8404735">US8404735</a></td><td class="patent-data-table-td patent-date-value">Apr 9, 2012</td><td class="patent-data-table-td patent-date-value">Mar 26, 2013</td><td class="patent-data-table-td ">Omnipharm Limited</td><td class="patent-data-table-td ">Parasiticidal formulation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8445519">US8445519</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 11, 2010</td><td class="patent-data-table-td patent-date-value">May 21, 2013</td><td class="patent-data-table-td ">Aventis Agriculture</td><td class="patent-data-table-td ">1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8450357">US8450357</a></td><td class="patent-data-table-td patent-date-value">Nov 13, 2009</td><td class="patent-data-table-td patent-date-value">May 28, 2013</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8475818">US8475818</a></td><td class="patent-data-table-td patent-date-value">Aug 30, 2007</td><td class="patent-data-table-td patent-date-value">Jul 2, 2013</td><td class="patent-data-table-td ">E. I. De Pont De Nemours And Company</td><td class="patent-data-table-td ">Local topical administration formulations containing indoxacarb</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8580837">US8580837</a></td><td class="patent-data-table-td patent-date-value">Mar 18, 2010</td><td class="patent-data-table-td patent-date-value">Nov 12, 2013</td><td class="patent-data-table-td ">Fidopharm, Inc.</td><td class="patent-data-table-td ">Parasiticidal formulation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8701597">US8701597</a></td><td class="patent-data-table-td patent-date-value">Oct 3, 2011</td><td class="patent-data-table-td patent-date-value">Apr 22, 2014</td><td class="patent-data-table-td ">Centers For Disease Control And Prevention</td><td class="patent-data-table-td ">Apparatus for applying chemicals to rodents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8785372">US8785372</a></td><td class="patent-data-table-td patent-date-value">May 15, 2013</td><td class="patent-data-table-td patent-date-value">Jul 22, 2014</td><td class="patent-data-table-td ">Aventis Agriculture</td><td class="patent-data-table-td ">1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20100249194">US20100249194</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 11, 2010</td><td class="patent-data-table-td patent-date-value">Sep 30, 2010</td><td class="patent-data-table-td ">Hyoung Ik Lee</td><td class="patent-data-table-td ">1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/CN101511795B?cl=en">CN101511795B</a></td><td class="patent-data-table-td patent-date-value">Jul 3, 2007</td><td class="patent-data-table-td patent-date-value">Sep 18, 2013</td><td class="patent-data-table-td ">安万特农业公司</td><td class="patent-data-table-td ">1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2465851A1?cl=en">EP2465851A1</a></td><td class="patent-data-table-td patent-date-value">Jul 3, 2007</td><td class="patent-data-table-td patent-date-value">Jun 20, 2012</td><td class="patent-data-table-td ">Aventis Agriculture</td><td class="patent-data-table-td ">1-Aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2550962A2?cl=en">EP2550962A2</a></td><td class="patent-data-table-td patent-date-value">Nov 13, 2009</td><td class="patent-data-table-td patent-date-value">Jan 30, 2013</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2639228A2?cl=en">EP2639228A2</a></td><td class="patent-data-table-td patent-date-value">May 12, 2008</td><td class="patent-data-table-td patent-date-value">Sep 18, 2013</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2005015995A1?cl=en">WO2005015995A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 3, 2004</td><td class="patent-data-table-td patent-date-value">Feb 24, 2005</td><td class="patent-data-table-td ">Hartz Mountain Corp</td><td class="patent-data-table-td ">High concentration topical insecticides containing pyrethroids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2005063015A1?cl=en">WO2005063015A1</a></td><td class="patent-data-table-td patent-date-value">Dec 17, 2004</td><td class="patent-data-table-td patent-date-value">Jul 14, 2005</td><td class="patent-data-table-td ">Merial Ltd</td><td class="patent-data-table-td ">Stabilized formulation of ivermerctin feed premix</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2008005489A2?cl=en">WO2008005489A2</a></td><td class="patent-data-table-td patent-date-value">Jul 3, 2007</td><td class="patent-data-table-td patent-date-value">Jan 10, 2008</td><td class="patent-data-table-td ">Aventis Agriculture</td><td class="patent-data-table-td ">1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2010065852A1?cl=en">WO2010065852A1</a></td><td class="patent-data-table-td patent-date-value">Dec 4, 2009</td><td class="patent-data-table-td patent-date-value">Jun 10, 2010</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Dimeric avermectin and milbemycin derivatives</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011014660A1?cl=en">WO2011014660A1</a></td><td class="patent-data-table-td patent-date-value">Jul 29, 2010</td><td class="patent-data-table-td patent-date-value">Feb 3, 2011</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Insecticidal 4-amino-thieno[2,3-d]-pyrimidine compounds and methods of their use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011069143A1?cl=en">WO2011069143A1</a></td><td class="patent-data-table-td patent-date-value">Dec 5, 2010</td><td class="patent-data-table-td patent-date-value">Jun 9, 2011</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Pesticidal bis-organosulfur compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011075591A1?cl=en">WO2011075591A1</a></td><td class="patent-data-table-td patent-date-value">Dec 16, 2010</td><td class="patent-data-table-td patent-date-value">Jun 23, 2011</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Anti parasitic dihydroazole compounds and compositions comprising same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011075592A1?cl=en">WO2011075592A1</a></td><td class="patent-data-table-td patent-date-value">Dec 16, 2010</td><td class="patent-data-table-td patent-date-value">Jun 23, 2011</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011123773A1?cl=en">WO2011123773A1</a></td><td class="patent-data-table-td patent-date-value">Apr 1, 2011</td><td class="patent-data-table-td patent-date-value">Oct 6, 2011</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Parasiticidal compositions comprising multiple active agents, methods and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012068202A1?cl=en">WO2012068202A1</a></td><td class="patent-data-table-td patent-date-value">Nov 16, 2011</td><td class="patent-data-table-td patent-date-value">May 24, 2012</td><td class="patent-data-table-td ">Centre National De La Recherche Scientifique (Cnrs)</td><td class="patent-data-table-td ">Novel monensin derivatives for the treatment and prevention of protozoal infections</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013003168A1?cl=en">WO2013003168A1</a></td><td class="patent-data-table-td patent-date-value">Jun 21, 2012</td><td class="patent-data-table-td patent-date-value">Jan 3, 2013</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Novel insect-repellent coumarin derivatives, syntheses, and methods of use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013003505A1?cl=en">WO2013003505A1</a></td><td class="patent-data-table-td patent-date-value">Jun 27, 2012</td><td class="patent-data-table-td patent-date-value">Jan 3, 2013</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Amido-pyridyl ether compounds and compositions and their use against parasites</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013039948A1?cl=en">WO2013039948A1</a></td><td class="patent-data-table-td patent-date-value">Sep 12, 2012</td><td class="patent-data-table-td patent-date-value">Mar 21, 2013</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013044118A2?cl=en">WO2013044118A2</a></td><td class="patent-data-table-td patent-date-value">Sep 21, 2012</td><td class="patent-data-table-td patent-date-value">Mar 28, 2013</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Indirect modeling of new repellent molecules active against insects, acarids, and other arthropods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013074892A1?cl=en">WO2013074892A1</a></td><td class="patent-data-table-td patent-date-value">Nov 16, 2012</td><td class="patent-data-table-td patent-date-value">May 23, 2013</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013082373A1?cl=en">WO2013082373A1</a></td><td class="patent-data-table-td patent-date-value">Nov 30, 2012</td><td class="patent-data-table-td patent-date-value">Jun 6, 2013</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Long-acting injectable moxidectin formulations and novel moxidectin crystal forms</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013119442A1?cl=en">WO2013119442A1</a></td><td class="patent-data-table-td patent-date-value">Jan 31, 2013</td><td class="patent-data-table-td patent-date-value">Aug 15, 2013</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013126694A1?cl=en">WO2013126694A1</a></td><td class="patent-data-table-td patent-date-value">Feb 22, 2013</td><td class="patent-data-table-td patent-date-value">Aug 29, 2013</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Topical compositions comprising fipronil and permethrin and methods of use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013158894A1?cl=en">WO2013158894A1</a></td><td class="patent-data-table-td patent-date-value">Apr 18, 2013</td><td class="patent-data-table-td patent-date-value">Oct 24, 2013</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013159094A2?cl=en">WO2013159094A2</a></td><td class="patent-data-table-td patent-date-value">Apr 22, 2013</td><td class="patent-data-table-td patent-date-value">Oct 24, 2013</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Improved processes for the preparation of 1-aryl-5-alkyl pyrazole compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014081697A2?cl=en">WO2014081697A2</a></td><td class="patent-data-table-td patent-date-value">Nov 19, 2013</td><td class="patent-data-table-td patent-date-value">May 30, 2014</td><td class="patent-data-table-td ">Merial Limited</td><td class="patent-data-table-td ">Anthelmintic compounds and compositions and method of using thereof</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S405000">424/405</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S407000">514/407</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S875000">514/875</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0047120000">A61K47/12</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0043560000">A01N43/56</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031440200">A61K31/4402</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0043500000">A01N43/50</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031416400">A61K31/4164</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0047100000">A61K47/10</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0025020000">A01N25/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0047140000">A61K47/14</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0037360000">A01N37/36</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0047340000">A01N47/34</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0037060000">A01N37/06</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0009080000">A61K9/08</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0047320000">A61K47/32</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0047200000">A61K47/20</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0043400000">A01N43/40</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0047380000">A61K47/38</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0047340000">A61K47/34</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0025000000">A01N25/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61P0033140000">A61P33/14</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031231000">A61K31/231</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0047080000">A61K47/08</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0025340000">A01N25/34</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0047020000">A01N47/02</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S514/875">Y10S514/875</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A01N43/56">A01N43/56</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pmJQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A01N47/02">A01N47/02</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A01N47/02</span>, <span class="nested-value">A01N43/56</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Feb 1, 2012</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">12</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 4, 2011</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">THE PATENTABILITY OF CLAIM 1 IS CONFIRMED. CLAIMS 6-11, 13-14, 17-25, 27-28, 42-48, 54-62, AND 68 ARE CANCELLED. CLAIMS 2-5, 12, 15, 26, 63-65 AND 70 ARE DETERMINED TO BE PATENTABLE AS AMENDED. CLAIMS 16, 29-41, 49-53, 66-67 AND 69, DEPENDENT ON AN AMENDED CLAIM, ARE DETERMINED TO BE PATENTABLE. NEW CLAIMS 71-108 ARE ADDED AND DETERMINED TO BE PATENTABLE.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 16, 2010</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20100810</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 11, 2008</td><td class="patent-data-table-td ">REMI</td><td class="patent-data-table-td ">Maintenance fee reminder mailed</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 1, 2008</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 17, 2005</td><td class="patent-data-table-td ">CC</td><td class="patent-data-table-td ">Certificate of correction</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 2, 2004</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 9, 2003</td><td class="patent-data-table-td ">CC</td><td class="patent-data-table-td ">Certificate of correction</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 2, 1998</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">MERIAL, FRANCE</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CHANGE OF NAME;ASSIGNOR:RHONE MERIEUX;REEL/FRAME:009605/0875</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">19970731</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 27, 1997</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">RHONE MERIEUX, FRANCE</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:JEANNIN, PHILIPPE;REEL/FRAME:008590/0785</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">19970502</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U01ogcbrkIYn9W30Okn6_QSL7rmrw\u0026id=pmJQBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U3Q3gYBQSBcWJ1yBwEw2jN8-ixs8w\u0026id=pmJQBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U0vo5g1KClu7CccY9GvwSmGQs06aA","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Synergistic_mixture_containing_fipronil.pdf?id=pmJQBAABERAJ\u0026output=pdf\u0026sig=ACfU3U1zDKvQF4jyWZAjSi4ti-RCsbXL_w"},"sample_url":"http://www.google.com/patents/reader?id=pmJQBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>